ArticleScientific reports2025
Assessment of economic burden of lumpy skin disease in India using stochastic modeling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Uttarkashi-strain based goatpox vaccine provides inadequate protection against lumpy skin disease in cattle.Veterinary research communications · 2026Article
- Development and Validation of a Population Assay for the Seroprevalence of Lumpy Skin Disease.Microorganisms · 2026Article
- Humoral and cytokine responses to a heterologous goatpox vaccine in Mithun (Frontiers in immunology · 2026Article
- Development of a monoclonal antibody-based competitive ELISA for serological detection of lumpy skin disease virus.Frontiers in veterinary science · 2026Article
- Molecular epidemiological and spatiotemporal analysis of lumpy skin disease outbreaks in cattle from Karnataka, India.Frontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assessed the farm-level economic loss due to LSD in India and at disaggregate (state) level by collecting data from 2351 cattle farms covering seven states. Data were analyed using descriptive statistics and stochastic modeling with Monte Carlo simulations. Gujarat state reported the highest milk loss, with a median reduction of 74, 90, 60, 45, 15, 15, and 8 L per animal in Rajasthan, Gujarat, Tamil Nadu, Karnataka, Madhya Pradesh, Assam, and Odisha, respectively. Crossbred cattle experienced more milk loss per animal, ranging from USD 0.0 to 237.8. The median mortality loss per animal varied between USD 12.2 and 1,084. The substantial national loss was due to decreased milk production, followed by the loss of draught power, treatment cost, and vector management cost. Stochastic modelling estimated economic loss due to LSD in cattle in India was USD 2440.29 million (90% CI 2162.55-2716.15) / (INR 202,544.07 million (90% 179,491.65-2,225,440.45) during 2022 & 2023 with a highest loss of USD 314.18 million (90% CI 279.10-349.34)) in Rajasthan state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.